VTVT - Microcaps mostly among premarket gainers
Prevail Therapeutics (PRVL) +84% on being acquired by Lilly for ~$1.04B.OncoCyte Corporation (OCX) +63% after company enters agreement with Burning Rock Biotech.Anavex Life Sciences (AVXL) +40% as it's blarcamesine successful in mid-stage rett syndrome study.Mid-Con Energy Partners (MCEP) +29%.Bridgetown Holdings Limited (BTWN) +23%.Bridgetown Holdings Limited (BTWNU) +24%.Opiant Pharmaceuticals (OPNT) +23% as company secures additional BARDA grant of $3.5M for OPNT003.Blonder Tongue Laboratories (BDR) +17%.Veru (VERU) +18%.Humanigen (HGEN) +17%.Immuron (IMRN) +15%.Timber Pharmaceuticals (TMBR) +17% as company receives receives notice of allowance from USPTO for lead asset TMB-001.Contango Oil & Gas Company (MCF) +13%.Fortress Biotech (FBIO) +13% after company announces breakthrough therapy designation for CUTX-101, Copper Histidinate.vTv Therapeutics (VTVT) +12% after entering into a licensing agreement with Anteris Bio.BioCardia (BCDA) +11%.BioLineRx (BLRX) +9%.TCR2 Therapeutics (TCRR) +12%.Thunder Bridge Acquisition II (THBR) +9%.22nd Century Group (XXII) +9%.Evogene (EVGN) +8% after updating about its Novel Mode-of-Action Herbicide program.Proteostasis Therapeutics (PTI) +8% as company entered into a agreement for the sale of its Common Stock
For further details see:
Microcaps mostly among premarket gainers